Promoting antitumor efficacy by suppressing hypoxia via nano self-assembly of two irinotecan-based dual drug conjugates having a HIF-1α inhibitor
2019 ◽
Vol 7
(35)
◽
pp. 5352-5362
◽
Keyword(s):
Conjugated a hydrophobic HIF-1α inhibitor (YC-1) with a hydrophilic anticancer drug, irinotecan (Ir), into one molecular entity, provided a new insight into the design of smart nanodrug delivery systems to hypoxic tumor tissue.
2019 ◽
Vol 18
(15)
◽
pp. 2078-2092
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 25
(41)
◽
pp. 9586-9591
◽
Keyword(s):
2016 ◽
Vol 515
(1-2)
◽
pp. 515-526
◽
Keyword(s):
2013 ◽
Vol 6
(3)
◽
pp. 2113-2124
Keyword(s):